Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism?

Wang, Jiaqiang; Ge, Hong; Tian, Zhichao

Wang, Jiaqiang; Ge, Hong; Tian, Zhichao.

Affiliation

Wang J; Department of Bone and Soft Tissue, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province, 450008, People's Republic of China.
Ge H; Department of Radiotherapy, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province, 450008, People's Republic of China.
Tian Z; Department of Bone and Soft Tissue, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province, 450008, People's Republic of China.

Onco Targets Ther ; 16: 385-397, 2023.

Article de En | MEDLINE | ID: mdl-37313391

Mots clés

PD-1 inhibitor; PD-L1 inhibitor; immune checkpoint inhibitor; immunoradiotherapy; radiotherapy; sarcoma

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Onco Targets Ther Année: 2023 Type de document: Article Pays de publication: Nouvelle-Zélande

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google